Abstract
Bifidobacteria constitute a specific group of commensal bacteria that inhabit the gastrointestinal tracts of humans and other mammals. Bifidobacterium breve UCC2003 has previously been shown to utilize several plant-derived carbohydrates that include cellodextrins, starch, and galactan. In the present study, we investigated the ability of this strain to utilize the mucin- and human milk oligosaccharide (HMO)-derived carbohydrate sialic acid. Using a combination of transcriptomic and functional genomic approaches, we identified a gene cluster dedicated to the uptake and metabolism of sialic acid. Furthermore, we demonstrate that B. breve UCC2003 can cross feed on sialic acid derived from the metabolism of 3'-sialyllactose, an abundant HMO, by another infant gut bifidobacterial strain, Bifidobacterium bifidum PRL2010. © 2014, American Society for Microbiology.
Cite
CITATION STYLE
Egan, M., Motherway, M. O. C., Ventura, M., & van Sinderen, D. (2014). Metabolism of sialic acid by Bifidobacterium breve UCC2003. Applied and Environmental Microbiology, 80(14), 4414–4426. https://doi.org/10.1128/AEM.01114-14
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.